Trend toward survival benefit seen for REM-inhibition in ALS

For patients with amyotrophic lateral sclerosis (ALS), rapid eye movement (REM) inhibition via receipt of antidepressant medication is associated with a trend toward survival benefit, according to a study presented at the American Thoracic Society 2025 International Conference, held from May 18 to 21 in San Francisco.

Leave A Comment

Your email address will not be published. Required fields are marked *